Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism L-lactate dehydrogenase inhibitors(L-lactate dehydrogenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H22F2N4O4S3 |
InChIKeyWGFNHVCWSDXXPH-UHFFFAOYSA-N |
CAS Registry1964516-59-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 08 Oct 2020 |